Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Jan 07, 2021 1:02pm
205 Views
Post# 32243077

RE:Hold it Baby...

RE:Hold it Baby...Now is the time for a marketing push there are so many folks out there who want to be THTX investors but they don't know yet.
They have better than anticipated sales when many other companies in the field are struggling,they have a go for the new and innovative PDC trial and most certainly they will initiate the NASH phase 3 in few months with all these great prospects under their belt they have to make sure as many as possible understand the opportunity if they have get out there and knock doors, house by house, street by street, city by city, country by country....

Wino115 wrote: I would love to see it hold a US$3 handle today for once.  It's been 2 years of not being able to hold breakouts. I have been consistent in saying they need to have true value-enhancing developments that should lead to concrete and incontrovertible market cap support.  We're seeing a bit of it today and beginning to walk down those paths.  The biggest supports are still to come. But if we can eliminate the "downside" that it's worth $2 something and slowly narrow the future value focus into view at higher levels, we may be on that path of gaining some share price momentum back in to it which all the portfolio managers younger than 50 want to see before they buy.  Let's hold that $3 level today!!



<< Previous
Bullboard Posts
Next >>